Archives: Contractor Email

Dear Colleague,

The following concessionary prices have been granted for September 2020:

Drug Pack Size Concessionary Price
Alendronic acid 10mg tablets 28 £5.79
Amiodarone 200mg tablets 28 £2.30
Clonidine 25microgram tablets 112 £14.20
Donepezil 10mg tablets 28 £1.90
Duloxetine 20mg gastro-resistant capsules 28 £8.71
Enalapril 10mg tablets 28 £3.91
Enalapril 20mg tablets 28 £7.30
Erythromycin 250mg gastro-resistant tablets 28 £3.39
Estradiol 1mg tablets 84 £6.89
Estradiol 2mg tablets 84 £6.89
Exemestane 25mg tablets 30 £31.16
Hydroxyzine 10mg tablets 84 £1.75
Imipramine 25mg tablets 28 £6.10
Irbesartan 150mg tablets 28 £6.60
Naftidrofuryl 100mg capsules 84 £6.85
Olanzapine 20mg tablets 28 £6.81
Prednisolone 20mg tablets 30 £30.37
Rasagiline 1mg tablets 28 £17.73
Senna 7.5mg tablets 60 £2.76
Sertraline 100mg tablets 28 £8.50
Sertraline 50mg tablets 28 £4.10
Tacrolimus 0.1% ointment 30 £22.80
Tacrolimus 0.1% ointment 60 £44.95
Tolterodine 2mg tablets 56 £13.75
Valproic acid 150mg gastro-resistant capsules 100 £11.37
Valproic acid 500mg gastro-resistant capsules 100 £30.00
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets 28 £12.20
Valsartan 160mg capsules 28 £15.55
Valsartan 80mg capsules 28 £10.36

This is the first update of concessionary prices for September 2020.

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing.

Concessionary prices are also published on the CPNI website www.communitypharmacyni.co.uk

Kind regards,

Katherine

SENT FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development

Dear Colleague

MINIMISING RISKS OF COVID-19 OUTBREAKS IN HEALTHCARE SETTINGS

Please see attached letter from Dr Michael McBride, Chief Medical Officer and Prof Ian Young, Chief Scientific Advisor.

Please feel free to share with your pharmacy teams.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

FAO Pharmacies Contracted to Provide This Year’s HSCB Commissioned Flu Service

Dear Colleague,

MANAGEMENT OF SEASONAL FLU 2020/21

Please see attached letter from Dr Michael McBride, Chief Medical Officer, Prof Charlotte McArdle Chief Nursing Officer and Cathy Harrison, Chief Pharmaceutical Officer.

Further information will be provided as it becomes available.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear Colleague,

INDEPENDENT PRESCRIBING IN COMMUNITY PHARMACY

Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

We would encourage you to respond to the request within the letter to help inform important service developments within community pharmacy.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear Colleague,

Please find attached for your immediate attention, FMD Alert from Cathy Harrison, Chief Pharmaceutical Officer, DoH.  Please share this with your pharmacy teams.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear Contractor

Update on reforms to initial education and training of pharmacists

The Pharmaceutical Society NI and the General Pharmaceutical Council have jointly issued a further letter updating pharmacists on the major changes to the initial education and training of pharmacists that they are taking forward across the UK (attached).

This follows the recent letter sent on 28th July 2020 by the regulators and the UK Chief Pharmaceutical Officers which can be accessed here.

Summary

The letter contains information on the introduction of the common registration assessment, the introduction of the Foundation training year (to replace the pre-registration year) and proposals on the roll out of independent prescribing for all those completing the MPharm and Foundation year.

Action

Contractors are advised to read and note the content of the letter.

The CPNI team will continue to keep you informed of these developments.

Kind regards

Mike

Sent on behalf of Prof Mike Mawhinney | Head of Regulatory Affairs

Download